SINGAPORE, May 28, 2013 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I), a developer of leading-edge photonics technologies for medical,
industrial and scientific markets, today announced that the claim
construction hearing, also called a Markman hearing, for Zecotek
Imaging Systems Pte Ltd.'s legal action against defendants Saint-Gobain
Corporation and Philips will be held on July 2, 2013, before U.S.
District Judge Sara Lioi. During the Markman hearing, the court will
hear arguments regarding the language and interpretation of the Zecotek
patent at issue in the case. The hearing is considered a critical event
in a patent lawsuit as it will define the property rights for the
substances and chemical formulations of Zecotek's LFS scintillation
"We welcome the Markman hearing as our legal action against Saint-Gobain
and Philips for infringing on our LFS scintillation crystal patent
moves forward," said Dr. A.F. Zerrouk, Chairman, President, and CEO of
Zecotek Photonics Inc. "We will continue to vigorously enforce our
intellectual property rights to recover the significant damages
afflicted on Zecotek and our shareholders."
U.S. Patent # 7,132,060 was granted to Zecotek on November 6, 2006,
and covers the substances and chemical formulations used to grow
lutetium fine silicate (LFS) scintillation crystals. LFS scintillation
crystals are characterized by their combined high-light yield and
ultra-fast decay times and are used in medical scanning devices,
high-energy science experiments, and other industrial and security
applications. The lawsuit alleges that Saint-Gobain's LYSO crystals
infringe Zecotek's patent, and that Philips infringes by using those
crystals in the positron emission tomography medical scanning devices
Additionally, Zecotek accuses Saint-Gobain and Philips of willful
Zecotek is joined by its exclusive licensee for certain LFS crystals,
Beijing Opto-Electronics Technology Co. Ltd., as co-plaintiff. Zecotek
is being represented by Thomas Loop of Loop Intellectual Property Law
and Justin Nelson of Susman Godfrey LLP. Both firms are recognized
leaders in patent law and intellectual property litigation matters.
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek operates
three divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada, Korea, Russia, Singapore and U.S.A. The
management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners such as the European
Organization for Nuclear Research (Switzerland), Beijing
Opto-Electronics Technology Co. Ltd. (China), NuCare Medical Systems
(South Korea), National NanoFab Center (South Korea) and Anteryon BV
(Netherlands). For more information, visit www.zecotek.com.
This press release may contain forward-looking statements that are based
on management's expectations, estimates, projections and assumptions.
These statements are not guarantees of future performance and involve
certain risks and uncertainties, which are difficult to predict.
Therefore, actual future results and trends may differ materially from
what may have been stated.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of the content of
this news release. If you would like to receive news from Zecotek in
the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.